W. K. Chan

Secreted dengue virus NS1 is predominantly dimeric and in complex with high-density lipoprotein

S. Vasudevan, E. Ooi, Bing Liang Alvin Chew, 2022, bioRxiv.

Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.

Moon Y. F. Tay, S. Vasudevan, M. Y. Tay, 2013, Antiviral research.

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial.

J. Connolly, J. Low, Y. Cheung, 2014, The Lancet. Infectious diseases.

A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection.

P. Sexton, S. Vasudevan, D. Jans, 2014, The Journal of infectious diseases.